HOME >> BIOLOGY >> NEWS
Link identified between Alzheimer's disease and glaucoma

UK scientists have shown for the first time that key proteins involved in Alzheimer's disease are also implicated in glaucoma, the major cause of irreversible blindness worldwide. Research carried out at the UCL Institute of Ophthalmology and funded by the Wellcome Trust has also shown that novel drugs being trialled for Alzheimer's disease which target this protein may be used to treat glaucoma.

The research team has developed a new technology for visualising nerve cell damage in the retina, known as Detection of Apoptosing Retinal Cells. Using this technology, they demonstrated that the protein beta-amyloid, which causes the so-called "plaque" lesions in the brains of Alzheimer's patients, also leads to nerve cell death in the retina. The research is published online today in the journal Proceedings of the National Academy of Sciences of the USA.

"We've seen for the first time that there is a clear link between what causes Alzheimer's disease and one of the basic mechanisms behind glaucoma," says Dr Francesca Cordeiro from University College London, who led the study. Dr Cordeiro is also a consultant ophthalmologist at the Western Eye Hospital, London, specialising in glaucoma. "However, this doesn't mean that everyone with Alzheimer's will develop glaucoma or vice versa. Glaucoma has a number of risk factors."

Glaucoma affects over half a million in the UK and as many as 65 million people worldwide(1). Little is know about what exactly causes the disease, which causes damage to the optic nerve in the eye; although the disease is traditionally attributed to increased pressure in the eye (known as "intraocular pressure", and clinical treatments attempt to lower this pressure). However a significant number of patients continue to lose vision despite their pressure being well controlled. The new research opens up a new avenue of treatment in glaucoma which does not involve treating intraocular pressure.

Dr Cordeiro and colle
'"/>

Contact: Mike Findlay
m.findlay@wellcome.ac.uk
44-207-611-8612
Wellcome Trust
6-Aug-2007


Page: 1 2

Related biology news :

1. Gene identified for Crohns disease in children
2. New gene mutation identified in common type of dementia
3. Allergy molecule identified
4. Gene responsible for common hearing loss identified for first time
5. Muscle weakness: New mutation identified
6. Tumor vessels identified by unique molecular markers
7. Extra-aggressive form of idiopathic pulmonary fibrosis identified
8. Newly identified mechanism for silencing genes points to possible anti-cancer strategies
9. Pediatric cancer stem cell identified: understanding the origin of ERMS
10. New host species for avian influenza identified
11. Master regulatory gene of epithelial stem cells identified

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2019)... ... ... KICVentures announced today its plans to host an event at Becker’s 17th ... Chicago on Thursday, June 13th at 6:30 pm. The event will take place at ... Ticino Hospitality room in space #74T. , The event will feature three brief talks ...
(Date:6/11/2019)... ... June 12, 2019 , ... ... discovery services, Abveris plans to leverage the Geneious Biologics platform as a premium ... Chief Technology Officer at Abveris, says: “The Geneious team has done an excellent ...
(Date:6/6/2019)... ... June 05, 2019 , ... MedTech Breakthrough , an ... and medical technology market, announced that it has selected Medacta International’s MySpine® MC ... in the 2019 MedTech Breakthrough Awards program. , Medacta® is ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ROANOKE, Va. (PRWEB) , ... June 11, 2019 ... ... for microlearning engagement, and Carilion Clinic, a national leader in opioid treatment, announced ... in virtual care. , Mytonomy recently deployed its virtual care platform ...
(Date:6/11/2019)... ... 11, 2019 , ... A study released today in STEM ... able to incorporate into human CD34+ cells, modifying their gene expression and increasing ... the cells’ ability to lodge into bone marrow. This research performed by Prof. ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary forms ... cancer demand breakthrough therapies. Advances in immuno-oncology have led to the advent of Chimeric ... with engineered T cell receptors known as “CARs”. The CAR enables the final product ...
(Date:5/31/2019)... ... May 30, 2019 , ... World Compliance ... on July 08-09, 2019 in Boston, MA. This peer recommended interactive workshop is ... , The training will kick off with a compendial treatment of Data Integrity ...
Breaking Biology Technology:
Cached News: